These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9234293)

  • 1. Metabolic pathway of 2-deoxy-2-[18F]fluoro-D-talose in mice: trapping in tissue after phosphorylation by galactokinase.
    Haradahira T; Maeda M; Kato A; Kanazawa Y; Yamada M; Torii Y; Ichiya Y; Masuda K
    Nucl Med Biol; 1994 Feb; 21(2):269-76. PubMed ID: 9234293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of 2-deoxy-2-[18F]fluoro-D-galactose in the liver by phosphate and uridylate trapping.
    Ishiwata K; Ido T; Imahori Y; Yamaguchi K; Fukuda H; Tada M; Matsuzawa T
    Int J Rad Appl Instrum B; 1988; 15(3):271-6. PubMed ID: 3260229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biodistribution of a fluorine-18 labeled analogue of D-talose: 2-deoxy-2-[18F]fluoro-D-talose.
    Haradahira T; Kato A; Maeda M; Torii Y; Ichiya Y; Masuda K
    Int J Rad Appl Instrum A; 1992 May; 43(5):627-32. PubMed ID: 1325421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo metabolism and UTP-depleting action of 2-deoxy-2-fluoro-D-galactose.
    Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Keppler D
    Adv Enzyme Regul; 1990; 30():231-42. PubMed ID: 2403033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and actions of 2-deoxy-2-fluoro-D-galactose in vivo.
    Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Friedrich E; Lehmann J; Keppler D
    Eur J Biochem; 1990 May; 190(1):11-9. PubMed ID: 2114284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism.
    Ishiwata K; Tomura M; Ido T; Iwata R; Itoh J; Kameyama M
    Int J Rad Appl Instrum B; 1989; 16(8):775-81. PubMed ID: 2621112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma.
    Kaarstad K; Bender D; Bentzen L; Munk OL; Keiding S
    J Nucl Med; 2002 Jul; 43(7):940-7. PubMed ID: 12097467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19F NMR of 2-deoxy-2-fluoro-D-glucose for tumor diagnosis in mice. An NDP-bound hexose analog as a new NMR target for imaging.
    Kanazawa Y; Umayahara K; Shimmura T; Yamashita T
    NMR Biomed; 1997 Jan; 10(1):35-41. PubMed ID: 9251114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of 18F-FDG (2-fluoro-2-deoxy-D-glucose) in tumor cells].
    Shimmura T; Nemoto M; Ino S; Kurami M
    Kaku Igaku; 2003 Feb; 40(1):31-8. PubMed ID: 12701205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.
    Sørensen M; Mikkelsen KS; Frisch K; Bass L; Bibby BM; Keiding S
    J Nucl Med; 2011 Oct; 52(10):1566-72. PubMed ID: 21875925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Deoxy-2-[18F]fluoro-D-galactose: a new tracer for the measurement of galactose metabolism in the liver by positron emission tomography.
    Fukuda H; Matsuzawa T; Tada M; Takahashi T; Ishiwata K; Yamada K; Abe Y; Yoshioka S; Sato T; Ido T
    Eur J Nucl Med; 1986; 11(11):444-8. PubMed ID: 3486765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Deoxy-2-[18F]fluoro-D-galactose as an in vivo tracer for imaging galactose metabolism in tumors with positron emission tomography.
    Ishiwata K; Yamaguchi K; Kameyama M; Fukuda H; Tada M; Matsuzawa T; Muraishi K; Itoh J; Kawashima K; Takahashi T
    Int J Rad Appl Instrum B; 1989; 16(3):247-54. PubMed ID: 2785512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of deoxyfluoro-D-galactopyranoses in a study of yeast galactokinase specificity.
    Thomas P; Bessell EM; Westwood JH
    Biochem J; 1974 Jun; 139(3):661-4. PubMed ID: 4369372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.
    Sørensen M; Mikkelsen KS; Frisch K; Villadsen GE; Keiding S
    J Hepatol; 2013 Jun; 58(6):1119-24. PubMed ID: 23339954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and analysis of galactose metabolic pathway variants of a mouse liver cell line.
    Zaret KS; Stevens KA
    Mol Cell Biol; 1990 Sep; 10(9):4582-9. PubMed ID: 2167434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat.
    Southworth R; Parry CR; Parkes HG; Medina RA; Garlick PB
    NMR Biomed; 2003 Dec; 16(8):494-502. PubMed ID: 14696007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the mobility of a key region in human galactokinase: Impacts on catalysis and stability.
    McAuley M; Huang M; Timson DJ
    Bioorg Chem; 2018 Dec; 81():649-657. PubMed ID: 30253338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-D-galactose from Talose triflate and biodistribution in a porcine model.
    Frisch K; Bender D; Hansen SB; Keiding S; Sørensen M
    Nucl Med Biol; 2011 May; 38(4):477-83. PubMed ID: 21531284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosynthesis, rodent biodistribution, and metabolism of 1-deoxy-1-[18F]fluoro-D-fructose.
    Haradahira T; Tanaka A; Maeda M; Kanazawa Y; Ichiya YI; Masuda K
    Nucl Med Biol; 1995 Aug; 22(6):719-25. PubMed ID: 8535332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.